Thiol-disulphide Homeostasis in Patients with Schizophrenia: The Potential Biomarkers of Oxidative Stress in Acute Exacerbation of Schizophrenia

키워드

참고문헌 (59)

1. Murray AJ, "Oxidative stress and the pathophysiology and symptom profile of schizophrenia spectrum disorders", Front Psychiatry, 12, pp.703452~ (2021)
2. Anderson G, "Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 42, pp.1~4 (2013)
3. Albayrak Y, "Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia : A preliminary study", Prog Neuropsychopharmacol Biol Psychiatry, 45, pp.144~149 (2013)
4. Valko M, "Free radicals and antioxidants in normal physiological functions and human disease", Int J Biochem Cell Biol, 39, pp.44~84 (2007)
5. Sato A, "Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells", Stem Cell Res, 12, pp.119~131 (2014)
6. Zhang M, "A meta-analysis of oxidative stress markers in schizophrenia", Sci China Life Sci, 53, pp.112~124 (2010)
7. Flatow J, "Meta-analysis of oxidative stress in schizophrenia", Biol Psychiatry, 74, pp.400~409 (2013)
8. Ermakov EA, "Oxidative stress-related mechanisms in schizophrenia pathogenesis and new treatment perspectives", Oxid Med Cell Longev, 2021, pp.8881770~ (2021)
9. Akyol O, "The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant", antioxidant imbalance, 2002, pp.26, 995~1005
10. Ranjekar PK, "Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients", Psychiatry Res, 121, pp.109~122 (2003)
11. Yao JK, "Altered glutathione redox state in schizophrenia", Dis Markers, 22, pp.83~93 (2006)
12. Güneş M, "Evaluation of paraoxonase, arylesterase and malondialdehyde levels in schizophrenia patients taking typical, atypical and combined antipsychotic treatment", Clin Psychopharmacol Neurosci, 14, pp.345~350 (2016)
13. Solberg DK, "A fiveyear follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia", Acta Neuropsychiatr, 31, pp.202~212 (2019)
14. Fraguas D, "Oxidative stress and inflammation in first-episode psychosis : A systematic review and meta-analysis", Schizophr Bull, 45, pp.742~751 (2019)
15. Tsai MC, "Changes in oxidative stress markers in patients with schizophrenia : The effect of antipsychotic drugs", Psychiatry Res, 209, pp.284~290 (2013)
16. Bai ZL, "Serum oxidative stress marker levels in unmedicated and medicated patients with schizophrenia", J Mol Neurosci, 66, pp.428~436 (2018)
17. An H, "Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients", Transl Psychiatry, 8, pp.258~ (2018)
18. Gonzalez-Liencres C, "Oxidative stress in schizophrenia : A case-control study on the effects on social cognition and neurocognition", BMC Psychiatry, 14, pp.268~ (2014)
19. Thimraj TA, "Immunity and inflammation in health and disease:Emerging roles of nutraceuticals and functional foods in immune support", pp.79~98 (2017), Elsevier
20. Jensen KS, "Kinetic and thermodynamic aspects of cellular thiol-disulfide redox regulation", Antioxid Redox Signal, 11, pp.1047~1058 (2009)
21. Turell L, "The thiol pool in human plasma : The central contribution of albumin to redox processes", Free Radic Biol Med, 65, pp.244~253 (2013)
22. Jones DP, "Measuring the poise of thiol", disulfide couples in vivo, 2009, pp.47, 1329~1338
23. Cremers CM, "Oxidant sensing by reversible disulfide bond formation", J Biol Chem, 288, pp.26489~26496 (2013)
24. Erel O, "A novel and automated assay for thiol", disulphide homeostasis, 2014, pp.47, 326~332
25. Ergin Tuncay M, "Thiol disulfide homeostasis in psychiatric disorders : A comprehensive review", Prog Neuropsychopharmacol Biol Psychiatry, 123, pp.110719~ (2023)
26. Atagun MI, "Investigating the impact of the ECT on thiol-disulphide homeostasis in depressive disorders", Psychiatry and Clinical Psychopharmacology, 30, pp.1~8 (2020)
27. Cingi Yirün M, "Thiol", disulphide homeostasis in manic episode and remission phases of bipolar disorder, 2018, pp.72, 572~577
28. Ozkan Y, "Thiol", disulfide homeostasis in medication-naive children and adolescents with obsessive-compulsive disorder, 2021, pp.140, 159~164
29. Dogan HO, "Thiol disulfide homeostasis in schizophrenic patients using atypical antipsychotic drugs", Clin Psychopharmacol Neurosci, 16, pp.39~45 (2018)
30. Kulaksizoglu B, "Thiol", disulfide homeostasis in schizophrenic patients, 2018, pp.12, 102~106
31. Ünal K, "Thiol", disulphide homeostasis in schizophrenia patients with positive symptoms, 2018, pp.72, 281~284
32. Topcuoglu C, "Thiol", disulfide homeostasis in untreated schizophrenia patients, 2017, pp.251, 212~216
33. Mitra S, "Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 78, pp.1~11 (2017)
34. Chien YL, "Clinical implications of oxidative stress in schizophrenia : Acute relapse and chronic stable phase", Prog Neuropsychopharmacol Biol Psychiatry, 99, pp.109868~ (2020)
35. Erkoç Ş, "Validity and reliability of scale for the assessment of negative symptoms", Düşünen Adam, 4, pp.14~15 (1991)
36. Erkoç Ş, "Validity and reliability of scale for the assessment of positive symptoms", Düşünen Adam, 4, pp.20~24 (1991)
37. Bayram E, "Reliability and validity of the Turkish version of the barnes akathisia rating scale", Turk J Neurol, 23, pp.56~59 (2017)
38. Overall JE, "The brief psychiatric rating scale", Psychol Rep, 10, pp.799~812 (1962)
39. Andreasen NC, "Negative versus positive schizophrenia", pp.28~51 (1991), Springer
40. Guy W, "ECDEU Assessment manual for psychopharmacology revised edition", pp.217~222 (1976), US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs
41. Barnes TR, "A rating scale for drug-induced akathisia", Br J Psychiatry, 154, pp.672~676 (1989)
42. Simpson GM, "A rating scale for extrapyramidal side effects", Acta Psychiatr Scand Suppl, 212, pp.11~19 (1970)
43. Lieberman JA, "Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia : A 52-week randomized trial of clozapine vs chlorpromazine", Neuropsychopharmacology, 28, pp.995~1003 (2003)
44. Hosmer Jr DW, "Applied logistic regression" (2013), John Wiley & Sons
45. Erel Ö, "A sensitive indicator for the severity of COVID-19 : Thiol", Turk J Med Sci, 51, pp.921~928 (2021)
46. Goh XX, "Blood-based oxidation markers in medicated and unmedicated schizophrenia patients : A metaanalysis", Asian J Psychiatr, 67, pp.102932~ (2022)
47. Almulla AF, "The tryptophan catabolite or kynurenine pathway in schizophrenia : Meta-analysis reveals dissociations between central, serum, and plasma compartments", Mol Psychiatry, 27, pp.3679~3691 (2022)
48. Guler EM, "Oxidative stress and schizophrenia : A comparative cross-sectional study of multiple oxidative markers in patients and their first-degree relatives", Int J Clin Pract, 75, pp.e14711~ (2021)
49. Miyazaki I, "Dopaminergic neuron-specific oxidative stress caused by dopamine itself", Acta Med Okayama, 62, pp.141~150 (2008)
50. Juárez Olguín H, "The role of dopamine and its dysfunction as a consequence of oxidative stress", Oxid Med Cell Longev, 2016, pp.9730467~ (2016)
51. Rambaud V, "Oxidative stress and emergence of psychosis", Antioxidants(Basel), 11, pp.1870~ (2022)
52. Więdłocha M, "Oxidative stress biomarkers among schizophrenia inpatients", Brain Sci, 13, pp.490~ (2023)
53. Ayaydın H, "Impaired thiol", disulfide homeostasis in children diagnosed with autism : A case-control study, 2021, pp.71, 1394~1402
54. Öğütlü H, "Thiols and ceruloplasmin levels in serum of children with attention deficit hyperactivity disorder : A cross-sectional study", Psychiatry Res, 294, pp.113546~ (2020)
55. Erzin G, "Thiol", disulphide homeostasis in bipolar disorder, 2018, pp.261, 237~242
56. Baykan H, "Thiol", disulfide balance as a new oxidative marker in female patients with major depressive disorder, 2018, pp.19, 135~142
57. Kurhan F, "The evaluation of thiol", disulfide homeostasis and oxidative DNA damage in patients with obsessive compulsive disorder, 2022, pp.20, 240~247
58. Pinto JV, "On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders : A systematic review", Neurosci Biobehav Rev, 83, pp.97~108 (2017)
59. Hong J, "Anti-inflammatory strategies for schizophrenia : A review of evidence for therapeutic applications and drug repurposing", Clin Psychopharmacol Neurosci, 18, pp.10~24 (2020)

관련 논문AI추천